Acadia Pharmaceuticals Inc

NASDAQ:ACAD   3:59:58 PM EDT
16.83
+0.79 (+4.92%)
Other Pre-Announcement

Acadia Pharmaceuticals Reports First Quarter 2022 Financial Results

Published: 05/04/2022 21:32 GMT
Acadia Pharmaceuticals Inc (ACAD) - Acadia Pharmaceuticals Reports First Quarter 2022 Financial Results.
Q1 Sales Rose 8 Percent to $115.5 Million.
Q1 Loss per Share $0.70.
Sees FY Sales $510 Million to $560 Million.
Q1 Earnings per Share View $-0.60, Revenue View $121.9 Million -- Refinitiv Ibes Data (analyst estimates).
Is Reiterating Its Previously Provided Guidance Ranges.